05/14/2025 20:05
BeiGene Showcases Strength of Hematology Portfolio at EHA 2025 with New Data Highlighting BRUKINSA’s Leadership and Next-Generation Innovation

BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that will change its name to BeOne Medicines Ltd., today announced it will share data across a range of hematologic malignancies at the European Hematology Association (EHA) Congress in Milan, Italy, June 12–15. BeiGene has 31 abstracts accepted at EHA 2025, with four selected for oral presentations, featuring data from its best-in-class Bruton’s tyrosine kinase (BTK) inhibitor BRUKINSA® (zanubrutinib) and its inve...

06/04/2025 08:00
PUMA’s Voices of a RE:GENERATION Present 2024 Sustainability Report for Young Audiences

Sports company PUMA is making its 2024 sustainability report accessible for young audiences with the help of video and social media content created by the Gen-Z environmentalists that are part of the Voices of a RE:GENERATION initiative. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250604222348/en/ Sports company PUMA is making its 2024 sustainability re...